Jody says IVF is all-consuming but, despite heartbreak along the way, she has no regrets and no worries about becoming a ...

"I’ve never been able to make this face before in my life. Is this normal?” Ashley Warwick asks in her viral video ...

FP-001 42 mg is an investigational, sustained-release formulation of a GnRH agonist being developed for the treatment of CPP. It is designed to provide continuous suppression of gonadotropin secretion ...

Liverpool mom Emilly Murray, 35, struggled with her weight her entire life. After years of yo-yo dieting and binge eating, ...

A Liverpool mum who once weighed 22 stone has lost almost half her body weight after her dad bought her Mounjaro weight loss ...

People expect passion to fade over time. What they don't expect is for it to completely run out with someone they still love ...

A novel experimental vaccine against the nipah virus has succeeded in its first major test in humans; it has been shown to be ...

The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

Novo Nordisk A/S's oral Wegovy wins FDA approval, promising strong 2026 growth with market exclusivity and competitive ...

NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID versus placebo, at three months, from a single ...